title: Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.
abstract: Heparan sulfate proteoglycans (HSPGs) are key components of the extracellular matrix that mediate cell proliferation, invasion, and cellular signaling. The biological functions of HSPGs are linked to their co-stimulatory effects on extracellular ligands (e.g., WNTs) and the resulting activation of transcription factors that control mammalian development but also associated with tumorigenesis. We examined the expression profile of HSPG core protein syndecans (SDC1-4) and glypicans (GPC1-6) along with the enzymes that initiate or modify their glycosaminoglycan chains in human breast cancer (HBC) epithelial cells. Gene expression in relation to cell proliferation was examined in the HBC cell lines MCF-7 and MDA-MB-231 following treatment with the HS agonist heparin. Heparin increased gene expression of chain initiation and modification enzymes including EXT1 and NDST1, as well as core proteins SDC2 and GPC6. With HS/Wnt interactions established, we next investigated WNT pathway components and observed that increased proliferation of the more invasive MDA-MB-231 cells is associated with activation of the Wnt signaling pathway. Specifically, there was substantial upregulation (>5-fold) of AXIN1, WNT4A, and MYC in MDA-MB-231 but not in MCF-7 cells. The changes in gene expression observed for HSPG core proteins and related enzymes along with the associated Wnt signaling components suggest coordinated interactions. The influence of HSPGs on cellular proliferation and invasive potential of breast cancer epithelial cells are cell and niche specific. Further studies on the interactions between HSPGs and WNT ligands may yield clinically relevant molecular targets, as well as new biomarkers for characterization of breast cancer progression.
authors.affiliation: Genomics Research Centre, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
authors.forename: Rachel K
authors.initials: RK
authors.lastname: Okolicsanyi
authors.forename: Andre J
authors.initials: AJ
authors.lastname: van Wijnen
authors.forename: Simon M
authors.initials: SM
authors.lastname: Cool
authors.forename: Gary S
authors.initials: GS
authors.lastname: Stein
authors.forename: Lyn R
authors.initials: LR
authors.lastname: Griffiths
authors.forename: Larisa M
authors.initials: LM
authors.lastname: Haupt
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D063646:Carcinogenesis / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects; D005260:Female; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D019812:Heparan Sulfate Proteoglycans / Q000096:biosynthesis* / Q000235:genetics; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D061986:MCF-7 Cells; D060449:Wnt Signaling Pathway / Q000187:drug effects / Q000235:genetics*
chemical_list: D019812:Heparan Sulfate Proteoglycans; D006493:Heparin
keywords: BREAST CANCER; GENE EXPRESSION; HEPARAN SULFATE PROTEOGLYCANS; MCF-7; MDA-MB-231; Wnt SIGNALING